Literature DB >> 25809919

Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology group.

P Quaglino1, P Fava1, M Caproni2, E Antiga2, C De Simone3, M Papini4, A Parodi5, M Novelli1, S Osella-Abate1, S Ribero1, M Sanlorenzo1, R Ponti1, M T Fierro1, A V Marzano6, P Savoia1.   

Abstract

BACKGROUND: No data are available as to the phenotype of circulating lymphocyte subsets in pyoderma gangrenosum (PG). AIM: To analyse the expression of different chemokine receptors associated to T-helper (Th)1 (CCR5), Th2 (CCR4) and Th17 (CCR6), as well as the regulatory T-cell subset (Treg) and dendritic cell polarization in the blood of newly diagnosed untreated PG patients.
MATERIALS AND METHODS: Multi-parameter flow cytometry was performed on blood samples from 10 PG patients collected at first diagnosis among centres belonging to the Italian Immuno-pathology Group. Blood samples from 10 age- and sex-matched healthy controls (HC) were used as controls.
RESULTS: PG patients are characterized by an over-expression in the blood of the CD4+CCR5+ and CD4+CCR6+ and a down-regulation of CD4+CCR4+ counts with respect to healthy subjects. Moreover, they show increased levels of myeloid derived dendritic cells type1 and reduced levels of the Treg CD4+CD25highFOXP3+ subset.
CONCLUSIONS: The pattern of chemokine expression argues in favour of a Th1 (CCR5+) and Th17 (CCR6+) polarization with a down-regulation of Th2 (CCR4+).
© 2015 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2015        PMID: 25809919     DOI: 10.1111/jdv.13100

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  4 in total

1.  Pyoderma gangrenosum: From historical perspectives to emerging investigations.

Authors:  Misty M Hobbs; Alex G Ortega-Loayza
Journal:  Int Wound J       Date:  2020-05-06       Impact factor: 3.315

2.  T helper type 1-related molecules as well as interleukin-15 are hyperexpressed in the skin lesions of patients with pyoderma gangrenosum.

Authors:  E Antiga; R Maglie; W Volpi; B Bianchi; E Berti; A V Marzano; M Caproni
Journal:  Clin Exp Immunol       Date:  2017-06-23       Impact factor: 4.330

3.  Pyoderma gangrenosum developing in a patient treated with dupilumab.

Authors:  Jessica Nasseh; Henry Abi Rached; Ioana Dumitru; Delphine Staumont-Sallé; Frédéric Dezoteux
Journal:  JAAD Case Rep       Date:  2021-12-17

Review 4.  Paraneoplastic Dermatoses: A Brief General Review and an Extensive Analysis of Paraneoplastic Pemphigus and Paraneoplastic Dermatomyositis.

Authors:  Dario Didona; Luca Fania; Biagio Didona; Rüdiger Eming; Michael Hertl; Giovanni Di Zenzo
Journal:  Int J Mol Sci       Date:  2020-03-21       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.